338 related articles for article (PubMed ID: 37712959)
21. Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma.
Xue W; Qiu K; Dong B; Guo D; Fu J; Zhu C; Niu Z
Cancer Cell Int; 2023 Sep; 23(1):218. PubMed ID: 37759294
[TBL] [Abstract][Full Text] [Related]
22. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
Front Immunol; 2022; 13():990790. PubMed ID: 36248822
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer.
Zhong J; Shen X; Zhou J; Yu H; Wang B; Sun J; Wang J; Liu F
Front Oncol; 2023; 13():1077342. PubMed ID: 36998462
[TBL] [Abstract][Full Text] [Related]
24. Prognostic and immune microenvironment analysis of cuproptosis-related LncRNAs in breast cancer.
Pan Y; Zhang Q; Zhang H; Kong F
Funct Integr Genomics; 2023 Jan; 23(1):38. PubMed ID: 36640225
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
26. Leveraging a gene signature associated with disulfidptosis identified by machine learning to forecast clinical outcomes, immunological heterogeneities, and potential therapeutic targets within lower-grade glioma.
Zhou Y; Cao Y; Liu W; Wang L; Kuang Y; Zhou Y; Chen Q; Cheng Z; Huang H; Zhang W; Jiang X; Wang B; Ren C
Front Immunol; 2023; 14():1294459. PubMed ID: 38162649
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
Song S; Zhang M; Xie P; Wang S; Wang Y
Front Immunol; 2022; 13():978909. PubMed ID: 36341328
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer.
Liu Q; Ma JY; Wu G
Aging (Albany NY); 2021 Sep; 13(17):21385-21399. PubMed ID: 34499616
[TBL] [Abstract][Full Text] [Related]
29. Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis.
Zhao F; Su L; Wang X; Luan J; Zhang X; Li Y; Li S; Hu L
Clin Epigenetics; 2024 Feb; 16(1):26. PubMed ID: 38342890
[TBL] [Abstract][Full Text] [Related]
30. Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer.
Li J; Zhang W; Ma X; Wei Y; Zhou F; Li J; Zhang C; Yang Z
Front Pharmacol; 2023; 14():1192434. PubMed ID: 37521466
[No Abstract] [Full Text] [Related]
31. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
Front Oncol; 2022; 12():988680. PubMed ID: 36203428
[TBL] [Abstract][Full Text] [Related]
32. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
[TBL] [Abstract][Full Text] [Related]
33. Disulfidptosis characterizes the tumor microenvironment and predicts immunotherapy sensitivity and prognosis in bladder cancer.
Pan G; Xie H; Xia Y
Heliyon; 2024 Feb; 10(3):e25573. PubMed ID: 38356551
[TBL] [Abstract][Full Text] [Related]
34. Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma.
Lan T; Ren S; Hu H; Wang R; Chen Q; Wu F; Xu Q; Li Y; Shao L; Wang L; Liu X; Cao H; Li J
Recent Pat Anticancer Drug Discov; 2024; 19(3):354-372. PubMed ID: 38214321
[TBL] [Abstract][Full Text] [Related]
35. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
Li Y; Zeng X
Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
[No Abstract] [Full Text] [Related]
36. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis heterogeneity within the tumor microenvironment revealed a genetic blueprint of breast cancer.
Qiu Z; Deng C; Zhou F; Chen Y; Chen X; Liu X; Ye C; Jin N
Environ Toxicol; 2024 May; 39(5):2741-2752. PubMed ID: 38251953
[TBL] [Abstract][Full Text] [Related]
38. Disulfidptosis-related genes of prognostic signature and immune infiltration features in hepatocellular carcinoma supported by bulk and single-cell RNA sequencing data.
Wang Y; Yuan Z; Zhu Q; Ma J; Lu Q; Xiao Z
J Gastrointest Oncol; 2024 Feb; 15(1):377-396. PubMed ID: 38482234
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a disulfidptosis and M2 TAM-related classifier for bladder cancer to explore tumor subtypes, immune landscape and drug treatment.
Ren C; Wang Q; Xu Z; Pan Y; Li Y; Liu X
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15805-15818. PubMed ID: 37668798
[TBL] [Abstract][Full Text] [Related]
40. Signature Construction and Disulfidptosis-Related Molecular Cluster Identification for Better Prediction of Prognosis in Glioma.
Zhuang Y; Chen J; Mai Z; Huang W; Zhong W
J Mol Neurosci; 2024 Apr; 74(2):38. PubMed ID: 38573391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]